Founder of Viamet Pharmaceuticals, Inc., Robert J. Schotzinger currently is President, Chief Executive Officer & Director at Viamet Pharmaceuticals Corp.
He is also on the board of Innocrin Pharmaceuticals Holdings LLC, Innocrin Pharmaceuticals, Inc., Arrevus, Inc. and Propella Therapeutics, Inc.
In his past career Dr. Schotzinger held the position of President & Chief Executive Officer for BioStratum, Inc., Vice President-Drug Development at Abbott Laboratories and President, Chief Executive Officer & Director at Viamet Pharmaceuticals, Inc.
He received an undergraduate degree from The Ohio State University and a doctorate from Case Western Reserve University.
|